Logo image of BRO.CA

BARKSDALE RESOURCES CORP (BRO.CA) Stock Fundamental Analysis

TSX-V:BRO - TSX Venture Exchange - CA06766T1075 - Common Stock - Currency: CAD

0.085  0 (-5.56%)

Fundamental Rating

0

Overall BRO gets a fundamental rating of 0 out of 10. We evaluated BRO against 0 industry peers in the Unkown industry. BRO may be in some trouble as it scores bad on both profitability and health. BRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BRO had negative earnings in the past year.
In the past year BRO has reported a negative cash flow from operations.
BRO had negative earnings in each of the past 5 years.
BRO had a negative operating cash flow in each of the past 5 years.
BRO.CA Yearly Net Income VS EBIT VS OCF VS FCFBRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -14.05%
ROE -15.26%
ROIC N/A
ROA(3y)-15.27%
ROA(5y)-16.17%
ROE(3y)-17.28%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
BRO.CA Yearly ROA, ROE, ROICBRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRO.CA Yearly Profit, Operating, Gross MarginsBRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BRO has more shares outstanding
Compared to 5 years ago, BRO has more shares outstanding
Compared to 1 year ago, BRO has an improved debt to assets ratio.
BRO.CA Yearly Shares OutstandingBRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BRO.CA Yearly Total Debt VS Total AssetsBRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BRO has an Altman-Z score of 1.21. This is a bad value and indicates that BRO is not financially healthy and even has some risk of bankruptcy.
BRO has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACCN/A
WACCN/A
BRO.CA Yearly LT Debt VS Equity VS FCFBRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

BRO has a Current Ratio of 0.44. This is a bad value and indicates that BRO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.44 indicates that BRO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
BRO.CA Yearly Current Assets VS Current LiabilitesBRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

BRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.19%, which is quite good.
EPS 1Y (TTM)12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRO.CA Yearly EPS VS EstimatesBRO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2025 -0.01 -0.02 -0.03 -0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRO.CA Price Earnings VS Forward Price EarningsBRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRO.CA Per share dataBRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BARKSDALE RESOURCES CORP

TSX-V:BRO (5/6/2025, 7:00:00 PM)

0.085

0 (-5.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-27 2025-02-27
Earnings (Next)07-28 2025-07-28
Inst Owners18.03%
Inst Owner ChangeN/A
Ins Owners3.26%
Ins Owner ChangeN/A
Market Cap11.52M
Analysts84.44
Price Target0.2 (135.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-50%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.05%
ROE -15.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.27%
ROA(5y)-16.17%
ROE(3y)-17.28%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34893.5%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z 1.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)15158.3%
Cap/Depr(5y)10897.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.24%
OCF growth 3YN/A
OCF growth 5YN/A